ABOUT AMETRIS
Founded in 2004, Ametris (formerly ActiGraph) is a global digital health solutions provider transforming real-world patient data into validated clinical evidence. Our end-to-end platform combines advanced wearables, regulatory-aligned analytics, and expert scientific support across every phase of a clinical trial—from protocol design to regulatory submission. We serve leading pharmaceutical, biotech, and public health research organizations worldwide, backed by two decades of experience and a collaborative, science-first approach.
In 2026, Ametris joined Signant Health, uniting wearable-derived digital outcome measures with industry-leading eCOA solutions to give sponsors a single partner for integrated evidence generation. Together, we combine continuous sensor data with patient-reported outcomes for a more complete picture of patient health.
NEWS FEATURE
-
Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
Signant Health announced its acquisition of Ametris (formerly ActiGraph), a global digital health solutions provider. This strategic acquisition unites industry-leading eCOA solutions with validated, wearable-derived digital outcome measures.
DIGITAL ENDPOINTS LIBRARY
-
Explore how sensor-based digital health technologies can revolutionize the treatment and management of movement disorders by providing more accurate, patient-centered outcomes.
-
Find out how sensor-based digital health technologies (DHTs) offer direct, objective daily life assessments, accelerating NMD drug development.
-
Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.
-
Discover how recent advancements in wearable sensors and data science have provided the opportunities for objective and unobtrusive assessment of walking in the real world.
-
People with cancer emphasize quality of life (QOL) as an important health outcome across their journey. Explore how digital health technologies can collect patient-centric outcomes passively and remotely, minimizing the burden for people to participate in clinical trials.
-
Explore how an objective scratch measure is now achievable through the use of wrist-worn wearable technology that is both non-invasive and easy to implement.
-
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. Learn more in the available e-Book.
-
Wearable devices provide a low-burden and remote approach to quantifying people’s sleep. While difficult to estimate, learn how actigraphy is sensitive to treatment effects.
WEBINARS
CONTACT INFORMATION
Ametris
70 N Baylen St, Suite 400
Pensacola, FL 32502
UNITED STATES
Phone: 850.332.7900
Contact: Genevieve Baley
SOLUTIONS
- Movement Disorder: Cardinal Symptoms Monitoring Solution
- Adherence Monitoring Solutions: Choose The Right Level Of Support
- Adherence Monitoring Solutions: Maximize Your DHT Investment
- A Digital Health Solution For Continuous, Long-Term Cough Monitoring
- Trial Enablement Solutions
- Power Patient-Focused Data Collection Across Hybrid Clinical Trials
- Modernize Clinical Research With Continuous Digital Data
- Modernizing Clinical Research Through Digital Transformation
- Wearable Device Comparison Guide: Medical-Grade Or Consumer Device?
- Accelerate Clinical Development With Patient-Centered Digital Measures
- LEAP: A Multisensor Wearable For Patient-Centered Clinical Research
- CentrePoint: The Robust Digital Health Technology Platform
FEATURED ARTICLES
- Monitoring Atrial Fibrillation In Clinical Research: The Case For Continuous Wearable Assessment
- DECODE CRS: Accelerating Immunotherapy Access And De-risking CRS
- Optimizing Wearable Adherence In A Phase 3 Oncology Trial
- Sleep Assessment In Sleep Disorders
- Continuous Passive Monitoring's Effect On Sleep Disorder Research
- Tracking Functional Capacity To Advance Neuromuscular Disease Research
- Advancing Neuromuscular Research with Digital Endpoints
- Digital Endpoint Resource Guide: Sleep Disorders
- Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data
- Aligning Wearable Data Collection Tith Visit Schedules Through EDC Integration
- Continuous Cough Monitoring: Addressing Placebo Effects And Data Gaps
- Wearables For Optical Cardiovascular Monitoring
- Deriving Reliable Clinical Outcome Scores From Continuous DHT Data
- Digital Measurement Of Nocturnal Scratch In Atopic Dermatitis
- Digital Outcome Measures Approved As Primary Endpoint In Cardiopulmonary Study
- A Guide to Digital Endpoints in Respiratory Diseases
- A Guide To Digital Endpoints In Major Depressive Disorder
- Wearable DHT 101 For Clinical Research
- Digital Health Solution For CRS Detection And Prediction
- Cytokine Release Syndrome Monitoring